L04AC10 Secukinumab 150mg/1 ml
Frist:27 May 2026, 22:00 UTC
Ausschreibungsinformationen
TED EUSkopje, North Macedonia
- Art
- 16
- Verfahren
- open
- Referenznummer
- 292590-2026
- CPV
- 33600000
Biological therapy according tehnical specification
Skopje, North Macedonia
Biological therapy according tehnical specification